Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Cash from Operations (2024 - 2025)

Updated

Curanex Pharmaceuticals' Cash from Operations was -$857,404 in Q4 2025, compared with -$95,427 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Cash from Operations (2024 - 2025) Analysis & Trends

For FY2025, Cash from Operations at Curanex Pharmaceuticals came in at -$10.48 million.

  • In earlier years, Cash from Operations was -$555,575 in FY2024.
  • Quarterly Cash from Operations has moved between -$9.19 million (Q3 2025) and -$95,427 (Q4 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 8.62 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.44 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.57 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 835.00 Mn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -857,404.00
Sep 30, 2025 -9.19 Mn
Dec 31, 2024 -95,427.00
Sep 30, 2024 -129,943.00
API Access

Curanex Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CURX&period=max&api_key=YOUR_API_KEY